DrugPatentWatch Database Preview
Vincristine sulfate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for vincristine sulfate and what is the scope of patent protection?
Vincristine sulfate
is the generic ingredient in six branded drugs marketed by Acrotech, Lilly, Teva Parenteral, Bristol Myers Squibb, Abic, Abraxis Pharm, Fresenius Kabi Usa, Hospira, and Teva Pharms Usa, and is included in thirteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Vincristine sulfate has forty-six patent family members in sixteen countries.
There are thirteen drug master file entries for vincristine sulfate. Two suppliers are listed for this compound.
Summary for vincristine sulfate
International Patents: | 46 |
US Patents: | 3 |
Tradenames: | 6 |
Applicants: | 9 |
NDAs: | 13 |
Drug Master File Entries: | 13 |
Suppliers / Packagers: | 2 |
Bulk Api Vendors: | 41 |
Clinical Trials: | 139 |
Patent Applications: | 7,468 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in vincristine sulfate? | vincristine sulfate excipients list |
DailyMed Link: | vincristine sulfate at DailyMed |
Recent Clinical Trials for vincristine sulfate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Acrotech Biopharma | Phase 2 |
David Rizzieri, MD | Phase 2 |
Mayo Clinic | Phase 1 |
Pharmacology for vincristine sulfate
Drug Class | Vinca Alkaloid |
Medical Subject Heading (MeSH) Categories for vincristine sulfate
Paragraph IV (Patent) Challenges for VINCRISTINE SULFATE
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
ONCOVIN | INJECTABLE;INJECTION | vincristine sulfate | 014103 |
US Patents and Regulatory Information for vincristine sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | ONCOVIN | vincristine sulfate | INJECTABLE;INJECTION | 014103-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Fresenius Kabi Usa | VINCRISTINE SULFATE | vincristine sulfate | INJECTABLE;INJECTION | 076401-001 | Oct 28, 2003 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for vincristine sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | Start Trial | Start Trial |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | Start Trial | Start Trial |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for vincristine sulfate
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 7038501 | Start Trial |
Japan | 2014088444 | Start Trial |
Germany | 60115045 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.